Literature DB >> 9028951

Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA.

H Mikkola1, L Muszbek, E Laiho, M Syrjälä, E Hämäläinen, G Haramura, T Salmi, L Peltonen, A Palotie.   

Abstract

Congenital factor XIII (FXIII) deficiency is potentially a severe bleeding disorder, but in some cases, the symptoms may be fairly mild. In this study, we have characterized the molecular mechanism of a mild phenotype of FXIII A-subunit deficiency in a Finnish family with two affected sisters, one of whom has even had two successful pregnancies without regular substitution therapy. In the screening tests for FXIII deficiency, no A-subunit could be detected, but by using more sensitive assays, a minute amount of functional A-subunit was seen. 3H-putrescine incorporation assay showed distinct FXIII activity at the level of 0.35% of controls, and also the fibrin cross-linking pattern in the patients clotted plasma showed partial gamma-gamma dimerization. In Western blot analysis, a faint band of full-length FXIII A-subunit was detected in the patients' platelets. The patients have previously been identified as heterozygotes for the Arg661 --> Stop mutation. Here we report a T --> C transition at position +6 of intron C in their other allele. The transition affected splicing of FXIII mRNA resulting in low steady state levels of several variant mRNA transcripts. One transcript contained sequences of intron C, whereas two transcripts resulted from skipping of one or two exons. Additionally, correctly spliced mRNA lacking the Arg661 --> Stop mutation of the maternal allele could be detected. These results demonstrate that a mutation in splice donor site of intron C can result in several variant mRNA transcripts and even permit partial correct splicing of FXIII mRNA. Further, even the minute amount of correctly processed mRNA is sufficient for producing protein capable of gamma-gamma dimerization of fibrin. This is a rare example of an inherited functional human disorder in which a mutation affecting splicing still permits some correct splicing to occur and this has a beneficial effect to the phenotype of the patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028951

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Splice-Site Mutation of Exon 3 Deletion in the Gamma-Glutamyl Carboxylase Gene Causes Inactivation of the Enzyme.

Authors:  Da-Yun Jin; Cees Vermeer; Darrel W Stafford; Jian-Ke Tie
Journal:  J Invest Dermatol       Date:  2016-07-06       Impact factor: 8.551

2.  Identification of a novel mutation combination in factor XIII deficiency: genetic update to the first reported case in the United States.

Authors:  Amy Halverstadt; Sean Walsh; Stephen M Roth; Robert E Ferrell; James M Hagberg
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

3.  Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation.

Authors:  Katharina Hess; Ramzi Ajjan; Fladia Phoenix; József Dobó; Péter Gál; Verena Schroeder
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 4.  [Identification of genetic defects in a Chinese pedigree with factor XIII deficiency: case report and literature review].

Authors:  Guanqun Xu; Qian Liang; Liwei Zhang; Yun Shen; Qiulan Ding; Xuefeng Wang; Hongli Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2015-10

5.  As little as needed: the extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene.

Authors:  Cristina Sobacchi; Alessandra Pangrazio; Antonio González-Meneses Lopez; Diego Pascual-Vaca Gomez; Maria Elena Caldana; Lucia Susani; Paolo Vezzoni; Anna Villa
Journal:  J Bone Miner Res       Date:  2014-07       Impact factor: 6.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.